Weikang Bio-Technology Group Co., Inc.

22 articles about Weikang Bio-Technology Group Co., Inc.

• Weikang Bio-Technology Group Co., Inc., Inc. Announces Fiscal Year 2011 Financial Results

  4/2/2012

• Weikang Bio-Technology Group Co., Inc. Completes HQ Relocation After Purchasing Building for $14 Million and Answers Questions About Its Third Quarter Financials

  12/28/2011

• Weikang Bio-Technology Group Co., Inc. Audit Committee Announces Results of Grant Thornton Report on Cash Balances

  6/7/2011

• Weikang Bio-Technology Group Co., Inc. Announces Fiscal 2010 Financial Results

  3/22/2011

• Weikang Bio-Technology Group Co., Inc. to Present at Rodman & Renshaw Annual China Investment Conference

  3/4/2011

• Weikang Bio-Technology Group Co., Inc. Announces Completion of $5.0 Million Private Placement

  2/1/2011

• Weikang Bio-Technology Group Co., Inc. Announces Inclusion of Ranitidine Hydrochloride Capsule on National Drug Reimbursement List

  1/27/2011

• Weikang Bio-Technology Group Co., Inc. Announces Fourth Quarter Revenue Contribution from Newest Sales Agents

  1/24/2011

• Weikang Bio-Technology Group Co., Inc. Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share

  1/18/2011

• Weikang Bio-Technology Group Co., Inc. Engages RedChip Companies to Lead Public and Investor Relations Efforts

  1/12/2011

• Weikang Bio-Technology Group Co., Inc. Announces Update on Newest Products

  1/11/2011

• Weikang Bio-Technology Group Co., Inc. Issues Fiscal 2011 Revenue Guidance of $71 - $82 Million and Net Profit of $27 - $31 million or $0.97 - $1.12 Earnings per Share

  11/29/2010

• Weikang Bio-Technology Group Co., Inc. to Present at PHARMCHINA'S 64th National Drug Fair Conference

  11/24/2010

• Weikang Bio-Technology Group Co., Inc. Signs Three New Agent Contracts Which are Expected to Add $15 Million in Annual Sales

  11/22/2010

• Weikang Bio-Technology Group Co., Inc. Reports Record Third Quarter 2010 Financial Results; Revenue of $17 Million and Non-GAAP Net Income of $6.5 Million or $0.23 Earnings per Share

  11/15/2010

• Weikang Bio-Technology Group Co., Inc. to Announce Third Quarter Earnings on Monday, November 15

  11/11/2010

• Weikang Bio-Technology Group Co., Inc. Reiterates Fiscal 2010 Revenue Guidance of $55 Million and Net Profit of $21 Million for $0.75 Earnings per Share

  10/11/2010

• Weikang Bio-Technology Group Co., Inc. Plans to Launch New Therapeutics in First Quarter 2011

  10/4/2010

• Weikang Bio-Technology Group Co., Inc. Retains Elite IR as Investor Relations Counsel to Expand Investor Awareness

  5/12/2010

• Weikang Bio-Technology Group Co., Inc. Appoints New Independent Members to Board of Directors

  4/16/2010